IBRN vs. EDOC
IBRN (iShares Neuroscience and Healthcare ETF) and EDOC (Global X Telemedicine & Digital Health ETF) are both Health & Biotech Equities funds - IBRN tracks the NYSE FactSet Global Neuro Biopharma and MedTech Index while EDOC tracks the Solactive Telemedicine & Digital Health Index- TR Net. Both are passively managed. Over the past 3 years, IBRN returned 16.48%/yr vs -7.38%/yr for EDOC. A 0.59 correlation means they provide meaningful diversification when combined. IBRN charges 0.47%/yr vs 0.68%/yr for EDOC.
Performance
IBRN vs. EDOC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBRN achieves a 18.23% return, which is significantly higher than EDOC's -2.48% return.
IBRN
- 1D
- -2.16%
- 1M
- 9.69%
- 6M
- 19.74%
- YTD
- 18.23%
- 1Y
- 69.86%
- 3Y*
- 16.48%
- 5Y*
- —
- 10Y*
- —
EDOC
- 1D
- 0.90%
- 1M
- 10.17%
- 6M
- -8.11%
- YTD
- -2.48%
- 1Y
- -7.84%
- 3Y*
- -7.38%
- 5Y*
- -12.35%
- 10Y*
- —
IBRN vs. EDOC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
IBRN iShares Neuroscience and Healthcare ETF | 18.23% | 28.49% | -2.78% | 0.92% | 2.87% |
EDOC Global X Telemedicine & Digital Health ETF | -2.48% | -0.62% | -2.87% | -12.61% | -10.02% |
Correlation
The correlation between IBRN and EDOC is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Aug 26, 2022 | 0.59 |
The correlation between IBRN and EDOC has been stable across timeframes, ranging from 0.51 to 0.59 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBRN vs. EDOC — Risk / Return Rank
IBRN
EDOC
IBRN vs. EDOC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and Global X Telemedicine & Digital Health ETF (EDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBRN | EDOC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.11 | ||
| Sortino ratioReturn per unit of downside risk | +3.96 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 0.96 | +0.46 |
| Calmar ratioReturn relative to maximum drawdown | 7.98 | -0.26 | +8.23 |
| Martin ratioReturn relative to average drawdown | 22.47 | -0.48 | +22.96 |
Loading charts...
Drawdowns
IBRN vs. EDOC - Drawdown Comparison
The maximum IBRN drawdown since its inception was -35.38%, smaller than the maximum EDOC drawdown of -65.76%. Use the drawdown chart below to compare losses from any high point for IBRN and EDOC.
Loading charts...
Drawdown Indicators
| IBRN | EDOC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.38% | -65.76% | +30.38% |
Max Drawdown (1Y)Largest decline over 1 year | -8.80% | -30.71% | +21.91% |
Max Drawdown (3Y)Largest decline over 3 years | -35.38% | -35.78% | +0.40% |
Max Drawdown (5Y)Largest decline over 5 years | — | -59.14% | — |
Current DrawdownCurrent decline from peak | -5.16% | -57.90% | +52.74% |
Average DrawdownAverage peak-to-trough decline | -9.63% | -43.33% | +33.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.12% | 16.31% | -13.19% |
Volatility
IBRN vs. EDOC - Volatility Comparison
The current volatility for iShares Neuroscience and Healthcare ETF (IBRN) is 6.66%, while Global X Telemedicine & Digital Health ETF (EDOC) has a volatility of 7.18%. This indicates that IBRN experiences smaller price fluctuations and is considered to be less risky than EDOC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBRN | EDOC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.66% | 7.18% | -0.52% |
Volatility (6M)Calculated over the trailing 6-month period | 19.29% | 17.10% | +2.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.51% | 22.68% | +2.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.34% | 26.59% | -1.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.34% | 26.29% | -0.95% |
IBRN vs. EDOC - Expense Ratio Comparison
IBRN has a 0.47% expense ratio, which is lower than EDOC's 0.68% expense ratio.
Dividends
IBRN vs. EDOC - Dividend Comparison
IBRN's dividend yield for the trailing twelve months is around 0.84%, more than EDOC's 0.25% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
EDOC Global X Telemedicine & Digital Health ETF | 0.25% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% |
IBRN iShares Neuroscience and Healthcare ETF | 0.84% | 0.99% | 0.40% | 0.06% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IBRN and EDOC have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EDOC has higher volatility (7.18%) compared to IBRN (6.66%). In terms of maximum drawdown, IBRN dropped -35.38% vs EDOC's -65.76%.
On 3-year performance, IBRN leads with 16.48% vs -7.38% for EDOC. On fees, IBRN is cheaper at 0.47% per year. On volatility, IBRN has been the lower-risk option at 6.66%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IBRN has performed better with a 16.48% return vs -7.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBRN is cheaper with a 0.47% expense ratio, compared with 0.68% for EDOC.
IBRN has the higher dividend yield at 0.84%, compared with 0.25% for EDOC.
IBRN tracks NYSE FactSet Global Neuro Biopharma and MedTech Index, while EDOC tracks Solactive Telemedicine & Digital Health Index- TR Net. They also come from different issuers: iShares and Global X. Their fees differ too: 0.47% for IBRN and 0.68% for EDOC.
IBRN currently has the higher Sharpe Ratio (2.76 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBRN and EDOC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer